Bain Capital Private Equity LP announced that it will acquire Showa Aircraft Industry Co., Ltd.
Mar 26, 2020
Mergers and Acquisitions
Showa Aircraft Industry Co., Ltd. engages in the manufacture and sale of aircraft equipment, light-alloy structures, and honeycomb core materials. It operates through the following segments: Transportation Equipment; Real Estate Leasing; Hotels, Sports, and Leisure; Product Sales; and Others. The Transportation Equipment segment offers special-purpose vehicle and aircraft instrumentation products. The Real Estate Leasing segment leases commercial facilities and buildings. The Hotels, Sports, and Leisure segment manages golf courses, sports facilities, and leisure hotels. The Product Sales segment offers sauna, fireplace, wood stove, welfare equipment and construction, and large motorcycle parts. The Others segment includes agriculture and welfare care businesses. The company was founded on June 5, 1937 and is headquartered in Tokyo, Japan.
In The News
May 13, 2020 - SNL Financial
Jan 24, 2020 - SNL Financial
Bain Capital Private Equity seeks produce superior investment returns for their investors. To achieve this, the firm adheres to 3 fundamental principles: a high-performance culture, a value-added investment approach and leveraging their institutional advantages. They tend to focus on investments in the software, hardware, information technology, healthcare and technology-driven business services sectors. The firm evaluates potential deal opportunities based on a people-intensive, consulting-based due diligence process that analyzes a company's financial performance, market growth potential, industry attractiveness and competitive position. Based on this analysis, and through close partnership with management, Bain Capital provides the needed support to successfully implement effective business plans that include acquisition development programs, corporate capital restructuring, scalable expansions designed to leverage competitive advantages and strategies for improving operating earnings.
In The News
May 20, 2020 - RelSci
Mar 08, 2020 - RelSci
Centrient Pharmaceuticals appoints Rex Clements as Chief Executive Officer after Karl Rotthier decides to step down from the role
Jan 29, 2020 - Thomson Reuters ONE